CAS No. |
54334-04-2 |
中文名称 |
(4S,4aR,5aR,6aR,6bR,9S,9aS,11aS,11bR)-9-[(S)-1-[(R)-4,5-二甲基-6-氧代-3,6-二氢-2H-吡喃-2-基]-1-羟基乙基]-4,6b,9-三羟基-9a,11b-二甲基-5a,6,6a,6b,7,8,9,9a,10,11,11a,11b-十二氢环戊[1,2]菲并[8a,9-b]环氧烯-1(4H)-酮 |
英文名称 |
(4S,4aR,5aR,6aR,6bR,9S,9aS,11aS,11bR)-9-((S)-1-((R)-4,5-dimethyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-1-hydroxyethyl)-4,6b,9-trihydroxy-9a,11b-dimethyl-5a,6,6a,6b,7,8,9,9a,10,11,11a,11b-dodecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxiren-1(4H)-one |
别名 |
4beta-Hydroxywithanolide E;4β-Hydroxywithanolide E;Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, δ-lactone, (4β,5β,6β,17α,22R)-;4β-HydroxywithanolideE;5β,6β-epoxy-4β,14,17α,20,22R-pentahydroxy-1-oxo-ergosta-2,24-dien-26-oic acid, ?-lactone |
标准英文名 |
(4S,4aR,5aR,6aR,6bR,9S,9aS,11aS,11bR)-9-((S)-1-((R)-4,5-dimethyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-1-hydroxyethyl)-4,6b,9-trihydroxy-9a,11b-dimethyl-5a,6,6a,6b,7,8,9,9a,10,11,11a,11b-dodecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxiren-1(4H)-one |
MDL No. |
MFCD01729182 |
分子式 |
C28H38O8 |
分子量 |
502.60
|
精确分子量 |
502.26
|
SMILES |
CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1 |
标准SMILES |
C[C@](O)([C@H]1CC(C)=C(C)C(=O)O1)[C@]1(O)CC[C@@]2(O)[C@@H]3C[C@H]4O[C@@]54[C@@H](O)C=CC(=O)[C@]5(C)[C@H]3CC[C@@]21C |
用途 |
4β-Hydroxywithanolide E is an adipogenesis inhibitor that suppresses the expression of PPARγ, C/EBPα, and the adipocyte-specific molecule aP2 mRNA; it inhibits adipocyte differentiation of 3T3-L1 cells by modulating mitotic clonal expansion. |
InChIKey |
UPBUGICUKQIKTJ-KABTZXSUSA-N |